SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001618835-21-000227
Filing Date
2021-11-09
Accepted
2021-11-09 16:52:06
Documents
6
Period of Report
2021-12-08

Document Format Files

Seq Description Document Type Size
1 DEF 14A specialmeetingdefiniteprox.htm DEF 14A 149070
2 alexa.jpg GRAPHIC 3430
3 evofembiosciencesinc_aut001a.jpg GRAPHIC 116094
4 evofembiosciencesinc_aut002a.jpg GRAPHIC 110361
5 evofembiosciencesjpegfileaa.jpg GRAPHIC 61097
6 spa.jpg GRAPHIC 5191
  Complete submission text file 0001618835-21-000227.txt   558387
Mailing Address 12400 HIGH BLUFF DRIVE SUITE 600 SAN DIEGO CA 92130
Business Address 12400 HIGH BLUFF DRIVE SUITE 600 SAN DIEGO CA 92130 (858) 550-1900
Evofem Biosciences, Inc. (Filer) CIK: 0001618835 (see all company filings)

IRS No.: 208527075 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36754 | Film No.: 211392990
SIC: 2834 Pharmaceutical Preparations